Why might epinephrine administration be more challenging in a patient taking beta-blockers?

• A. Beta-blockers blunt epinephrine response; no need for adjuncts
• B. Beta-blockers have no effect on epinephrine
• C. Beta-blockers enhance epinephrine response
• D. Beta-blockers may blunt the sympathetic response to epinephrine; may require adjunct measures per protocol

Answer: (D)

Epinephrine relies on beta receptors to produce many of its important effects, like increasing heart rate and contractility and promoting bronchodilation. When a patient is taking beta-blockers, those beta receptors are blocked, so epinephrine’s beta-mediated actions are blunted. That means the expected improvements in heart rate, cardiac output, and airway relief may be less than usual, making the response harder to achieve with standard dosing.

Because epinephrine can still act on alpha receptors, there may be unopposed vasoconstriction and variable blood pressure effects, which further complicates management. For this reason, treatment often requires adjunct measures per protocol—such as additional therapies or alternative vasopressors—to reach the desired clinical response when beta-blockade dampens epinephrine’s effectiveness.